(April 7, 2020) In a study published last week in the oncology Journal of the American Medical Association, breastfeeding was found to be a factor for reduced risk of developing invasive ovarian cancer… Read on
Friends, I hope this finds you well, or as well as can be expected during this challenging time. My wish for all of you is that you are feeling safe, and surrounded by caring community… Read on
(3/17/2020) Research out of the University of Bristol looked at genes and how they inhibit an enzyme involved in regulating the body’s cholesterol. This enzyme is the target of statin drugs, which are prescribed to lower cholesterol levels… Read on
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients… Read on
(January 15, 2020) A new study in the Journal of the American Medical Association (JAMA) found no statistically significant association between self-reported use of powder in the genital area and subsequent risk of developing ovarian cancer… Read on
(January 13, 2020) Thanks to your support, 22 top scientists at 19 eminent medical centers across the world will delve into important topics across the ovarian cancer landscape… Read on
(December 23, 2019) OCRA-funded scientist Dr. Sarah Gitto is making strides toward better harnessing the immune system to fight ovarian cancer. As reported recently in Gynecologic Oncology, Dr… Read on
OCRA-funded scientists have been hard at work this year, uncovering breakthroughs in ovarian cancer prevention, diagnostics, and treatment that can save women’s lives… Read on
(December 3, 2019) The origins of high grade serous ovarian carcinoma (HGSOC) is a debated topic in the scientific community… Read on
(November 13, 2019) A study recently published in Nature Communications and led by OCRA grantee Dr. Rugang Zhang showed that the ARID1A protein plays a fundamental role in ensuring correct chromosome segregation when the cells divide… Read on
